Antidiabetic effect of gynostemma pentaphyllum tea in randomly assigned type 2 diabetic patients

Hormone and Metabolic Research

Volumn 42, Issue 5, 2010, Pages 353-357

  Huyen, V T T ^a,b,c   Phan, D V ^b   Thang, P ^c   Hoa, N K ^a,b   Ostenson C G ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b HANOI MEDICAL UNIVERSITY   (Viet Nam)

^c National Institute of Gerontology   (Viet Nam)

Author keywords

Gynostemma pentaphyllum tea; Herbal medicine; Insulin sensitivity; Type 2 diabetes

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIDIABETIC AGENT; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; CREATININE; GLUCAGON; GLUCOSE; GYNOSTEMMA PENTAPHYLLUM EXTRACT; HEMOGLOBIN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROCORTISONE; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; TRIACYLGLYCEROL;

ABSENCE OF SIDE EFFECTS; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTHROPOMETRY; ANTIDIABETIC ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD PRESSURE MEASUREMENT; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROL GROUP; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC PATIENT; DIET; DOUBLE BLIND PROCEDURE; DRUG ACTIVITY; DRUG EFFECT; EXERCISE; FEMALE; GASTROINTESTINAL TRACT FUNCTION; GLUCAGON BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GYNOSTEMMA PENTAPHYLLUM; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MALE; NAUSEA AND VOMITING; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; ANTHROPOMETRY; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; GLUCOSE TOLERANCE TEST; GYNOSTEMMA; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; KIDNEY; LIPID METABOLISM; LIPIDS; LIVER; MALE; MIDDLE AGED; PLANT EXTRACTS;

GYNOSTEMMA PENTAPHYLLUM;

EID: 77952003251     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0030-1248298     Document Type: Article

References (39)

1. King H, Aubert RE, Herman WH. Global burden of diabetes, 19952025: prevalence, numerical estimates, and projections. Diabetes Care 1998 21 1414-1431 (Pubitemid 28405191)
2. Quoc PS, Charles MA, Cuong NH, Lieu LH, Tuan NA, Thomas M, Balkau B, Simon D. Blood glucose distribution and prevalence of diabetes in Hanoi (Vietnam). Am J Epidemiol 1994 139 713-722 (Pubitemid 24121280)
3. Baumann LC, Blobner D, Binh TV, Lan PT. A training program for diabetes care in Vietnam. Diabetes Educ 2006 32 189-194 (Pubitemid 43472148)
4. Schwarz PE, Schwarz J, Bornstein SR, Schulze J. Diabetes prevention from physiology to implementation. Horm Metab Res 2006 38 460-464
5. Schwarz PE, Li J, Tuomilehto J. Tools for predicting the risk of type 2 diabetes in daily practice. Horm Metab Res 2009 41 86-97
6. Schwarz PE, Muylle F, Valensi P, Diabetes Prevention Forum-IDF Europe. The European perspective of diabetes prevention. Horm Metab Res 2008 40 511-514
7. Wolsko PM, Eisenberg DM, Davis RB, Ettner SL, Phillips RS. Insurance coverage, medical conditions, and visits to alternative medicine providers: results of a national survey. Arch Intern Med 2002 162 281-287
8. Garrow D, Egede LE. National patterns and correlates of complementary and alternative medicine use in adults with diabetes. J Altern Complement Med 2006 12 895-902 (Pubitemid 44770982)
9. Saydah SH, Eberhardt M. Use of complementary and alternative medicine among adults with chronic diseases: United States 2002. J Altern Complement Med 2006 12 805-812 (Pubitemid 44934095)
10. Yeh GY, Eisenberg D, Kaptchuk TJ, Phillips RS. Systematic review of herbs and dietary supplements for glycemic control in diabetes. Diabetes Care 2003 26 1277-1294 (Pubitemid 36929285)
11. Wang E, Wylie-Rosett J. Review of selected Chinese herbal medicines in the treatment of type 2 diabetes. Diabetes Educ 2008 34 645-654
12. Angell M, Kassirer JP. Alternative Medicine-the risks of untested and unregulated remedies. N Engl J Med 1998 339 839-841 (Pubitemid 28447460)
13. Hoey J. The arrogance of science and the pitfalls of hope. CMAJ 1998 159 803-804 (Pubitemid 28497583)
14. Ernst E. Herbal medicines: where is the evidence? BMJ 2000 321 395-396 (Pubitemid 30609439)
15. Anonymous. Complementary medicine: Time for critical engagement. Lancet 2000 356 2023
16. Dalen JE. Conventional and unconventional medicine: can they be integrated? Arch Intern Med 1998 158 2179-2181
17. Fontanarosa PB, Lundberg GD. Alternative medicine meets science. JAMA 1998 280 1618-1619
18. Hoa NK, Phan DV, Thuan ND, Ostenson CG. Screening of the hypoglycemic effect of eight Vietnamese herbal drugs. Methods Find Exp Clin Pharmacol 2009 31 165-169
19. Norberg A, Hoa NK, Liepinsh E, Phan DV, Thuan ND, Jörnvall H, Sillard R, Ostenson CG. A novel insulin-releasing substance, phanoside, from the plant Gynostemma pentaphyllum. J Biol Chem 2004 279 41361-41367 (Pubitemid 39313575)
20. Hoa NK, Norberg A, Sillard R, Phan DV, Thuan ND, Dzung DT, Jörnvall H, Ostenson CG. The possible mechanisms by which phanoside stimulates insulin secretion from rat islets. J Endocrinol 2007 192 389-394 (Pubitemid 46444440)
21. Megalli S, Davies NM, Roufogalis BD. Anti-hyperlipidemic and hypoglycemic effects of Gynostemma pentaphyllum in the Zucker fatty rat. J Pharm Sci 2006 9 281-291 (Pubitemid 46614342)
22. Department of Material Medica, Hanoi College of Pharmacy. Textbook of Material Medica 2006 1 36-38
23. Department of Material Medica, Hanoi College of Pharmacy. Guideline of Material Medica practice 2006 1 16-17
24. World Health Organization. WHO, Definition, Diagnosis, and Classification of Diabetes Mellitus and Its Complications: Report of a WHO Consultation, Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva 1999
25. Herbert V, Lau KS, Gottlieb CW, Bleicher SJ. Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab 1965 25 1375-1384
26. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 28 412-419 (Pubitemid 15018832)
27. Roghani M, Baluchnejadmojarad T. Hypoglycemic and hypolipidemic effect and antioxidant activity of chronic epigallocatechin-gallate in streptozotocin-diabetic rats. Pathophysiology 2010 17 55-59
28. Nahas R, Moher M. Complementary and alternative medicine for the treatment of type 2 diabetes. Can Fam Physician 2009 55 591-596
29. Tsuneki H, Ishizuka M, Terasawa M, Wu JB, Sasaoka T, Kimura I. Effect of green tea on blood glucose levels and serum proteomic patterns in diabetic (db/db) mice and on glucose metabolism in healthy humans. BMC Pharmacol 2004 4 18 (Pubitemid 40177096)
30. Davidson MB, Peters AL. An overview of metformin in the treatment of type 2 diabetes mellitus. Am J Med 1997 102 99-110 (Pubitemid 27089992)
31. Attawish A, Chivapat S, Phadungpat S, Bansiddhi J, Techadamrongsin Y, Mitrijit O, Chaorai B, Chavalittumrong P. Chronic toxicity of Gynostemma Pentaphyllum. Fitoterapia 2004 75 539-551 (Pubitemid 39209435)
32. Lu KW, Tsai ML, Chen JC, Hsu SC, Hsia TC, Lin MW, Huang AC, Chang YH, Ip SW, Lu HF, Chung JG. Gypenosides inhibited invasion and migration of human tongue cancer SCC4 cells through down-regulation of NFkappaB and matrix metalloproteinase-9. Anticancer Res 2008 28 (2A) 1093-1099
33. Chen JC, Lu KW, Lee JH, Yeh CC, Chung JG. Gypenosides induced apoptosis in human colon cancer cells through the mitochondria-dependent pathways and activation of caspase-3. Anticancer Res 2006 26 (6B) 4313-4326 (Pubitemid 46031504)
34. Chou SC, Chen KW, Hwang JS, Lu WT, Chu YY, Lin JD, Chang HJ, See LC. The add-on effects of Gynostemma pentaphyllum on nonalcoholic fatty liver disease. Altern Ther Health Med 2006 12 34-39 (Pubitemid 43726080)
35. Lin CC, Huang PC, Lin JM. Antioxidant and hepatoprotective effects of Anoectochilus formosanus and Gynostemma pentaphyllum. Am J Chin Med 2000 28 87-96
36. Huang WC, Kuo ML, Li ML, Yang RC, Liou CJ, Shen JJ. Extract of Gynostemma pentaphyllum enhanced the production of antibodies and cytokines in mice. Yakugaku Zasshi 2007 127 889-896
37. Rujjanawate C, Kanjanapothi D, Amornlerdpison D. The anti-gastric ulcer effect of Gynostemma pentaphyllum Makino. Phytomedicine 2004 11 431-435 (Pubitemid 38980524)
38. Hesse C, Razmovski-Naumovski V, Duke CC, Davies NM, Roufogalis BD. Phytopreventative effects of Gynostemma pentaphyllum against acute Indomethacin-induced gastrointestinal and renal toxicity in rats. Phytother Res 2007 21 523-530 (Pubitemid 46910226)
39. Hung TM, Hoang DM, Kim JC, Jang HS, Ahn JS, Min BS. Protein tyrosine phosphatase 1B inhibitory activity by dammaranes from Vietnamese Giao-Co-Lam tea. J Ethnopharmacol 2009 124 240-245